Pathology: non squamous - mNSCLC - L1 - all population; non squamous - mNSCLC - L1 - Wild Type (WT); squamous - mNSCLC - L1 - all population;
| non squamous - mNSCLC - L1 - all population | non squamous - mNSCLC - L1 - Wild Type (WT) | squamous - mNSCLC - L1 - all population | ||
| IMpower-130 (all population), 2019 | IMpower-130 (WT), 2019 | IMpower-131 (ACnP), 2020 | ||
| atezolizumab plus carboplatin plus nab-paclitaxel | 3 | T1T0 | T1 | T1 |
| carboplatin plus nab-paclitaxel | 0 | T0 | T0 |